Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study.
Jesse PopovSuellen CoelhoMarc CarrierCatherine SperlichSusan SolymossNathalie RouthierSudeep ShivakumarWusiman AibibulaSusan R KahnVicky TagalakisPublished in: Journal of thrombosis and haemostasis : JTH (2022)
These results, in part, provide support for trials of extended reduced-dose anticoagulation for the secondary prevention of CAT. (ClinicalTrials.gov: NCT02752607).